PURPOSE: Manganese(II) is employed as a contrast agent with magnetic resonance imaging (MRI) for study of neuronal activation in rats and mice. However, at the concentrations required for MRI, Mn may induce pharmacological or toxic effects. Positron emission tomography (PET) imaging of (52)MnCl2 at tracer doses has the potential to allow similar Mn studies as manganese-enhanced MRI while providing quantitative results and avoiding toxic effects. In this work, (52)MnCl2 is produced and characterized as a PET tracer in phantoms and in rats. METHODS: (52)MnCl2 was produced by proton irradiation of natural Cr foil and separated by column chromatography. Images were acquired on a Siemens Focus 120 small animal PET scanner. Phantom images were acquired to assess uniformity, resolution, cascade background correction, and count rate linearity. Images of rats were also acquired after systemic and intracerebroventricular (ICV) administration of (52)MnCl2 to investigate Mn(II) distribution in vivo. RESULTS: Irradiation yield was 74.6 ± 8.5 kBq/μA min (52)Mn at end of bombardment with initial specific activity of at least 3.5 MBq/nmol. (52)Mn PET images show similar uniformity and resolution to (18)F. (18)F based detector efficiency normalization is adequate for (52)Mn imaging. Subtraction of a rescaled random events distribution from sinogram data is effective for cascade correction of (52)Mn PET data. After systemic injection, (52)Mn appears in structures throughout the body of rats, including bones, liver, intestines, and the pituitary gland, but does not appear detectably throughout the brain. After ICV injection, (52)Mn remains in the brain and spinal cord. CONCLUSIONS: (52)Mn is a promising tracer for small animal PET imaging, yielding image quality comparable to (18)F. Potential applications include studies similar to Mn-enhanced neuronal MRI, and in other organ systems including bones, spinal cord, and the digestive tract.
PURPOSE:Manganese(II) is employed as a contrast agent with magnetic resonance imaging (MRI) for study of neuronal activation in rats and mice. However, at the concentrations required for MRI, Mn may induce pharmacological or toxic effects. Positron emission tomography (PET) imaging of (52)MnCl2 at tracer doses has the potential to allow similar Mn studies as manganese-enhanced MRI while providing quantitative results and avoiding toxic effects. In this work, (52)MnCl2 is produced and characterized as a PET tracer in phantoms and in rats. METHODS: (52)MnCl2 was produced by proton irradiation of natural Cr foil and separated by column chromatography. Images were acquired on a Siemens Focus 120 small animal PET scanner. Phantom images were acquired to assess uniformity, resolution, cascade background correction, and count rate linearity. Images of rats were also acquired after systemic and intracerebroventricular (ICV) administration of (52)MnCl2 to investigate Mn(II) distribution in vivo. RESULTS: Irradiation yield was 74.6 ± 8.5 kBq/μA min (52)Mn at end of bombardment with initial specific activity of at least 3.5 MBq/nmol. (52)Mn PET images show similar uniformity and resolution to (18)F. (18)F based detector efficiency normalization is adequate for (52)Mn imaging. Subtraction of a rescaled random events distribution from sinogram data is effective for cascade correction of (52)Mn PET data. After systemic injection, (52)Mn appears in structures throughout the body of rats, including bones, liver, intestines, and the pituitary gland, but does not appear detectably throughout the brain. After ICV injection, (52)Mn remains in the brain and spinal cord. CONCLUSIONS: (52)Mn is a promising tracer for small animal PET imaging, yielding image quality comparable to (18)F. Potential applications include studies similar to Mn-enhanced neuronal MRI, and in other organ systems including bones, spinal cord, and the digestive tract.
Authors: Christina L Brunnquell; Reinier Hernandez; Stephen A Graves; Ivy Smit-Oistad; Robert J Nickles; Weibo Cai; M Elizabeth Meyerand; Masatoshi Suzuki Journal: Contrast Media Mol Imaging Date: 2016-07-11 Impact factor: 3.161
Authors: Stephen A Graves; Reinier Hernandez; Jesper Fonslet; Christopher G England; Hector F Valdovinos; Paul A Ellison; Todd E Barnhart; Dennis R Elema; Charles P Theuer; Weibo Cai; Robert J Nickles; Gregory W Severin Journal: Bioconjug Chem Date: 2015-09-10 Impact factor: 4.774
Authors: Stephen A Graves; Paul A Ellison; Todd E Barnhart; Hector F Valdovinos; Eva R Birnbaum; Francois M Nortier; Robert J Nickles; Jonathan W Engle Journal: Nucl Instrum Methods Phys Res B Date: 2016-09-28 Impact factor: 1.377
Authors: Stephen A Graves; Paul A Ellison; Hector F Valdovinos; Todd E Barnhart; Robert J Nickles; Jonathan W Engle Journal: Phys Rev C Date: 2017-07-18 Impact factor: 3.296
Authors: Nathan C Ni; Cheng S Jin; Liyang Cui; Zhengbo Shao; Jun Wu; Shu-Hong Li; Richard D Weisel; Gang Zheng; Ren-Ke Li Journal: Mol Imaging Biol Date: 2016-08 Impact factor: 3.488
Authors: Galit Saar; Corina M Millo; Lawrence P Szajek; Jeff Bacon; Peter Herscovitch; Alan P Koretsky Journal: Mol Imaging Biol Date: 2018-08 Impact factor: 3.488
Authors: Christina M Lewis; Stephen A Graves; Reinier Hernandez; Hector F Valdovinos; Todd E Barnhart; Weibo Cai; Mary E Meyerand; Robert J Nickles; Masatoshi Suzuki Journal: Theranostics Date: 2015-01-01 Impact factor: 11.556
Authors: Kendall E Barrett; Eduardo Aluicio-Sarduy; Steffen Happel; Aeli P Olson; Christopher J Kutyreff; Paul A Ellison; Todd E Barnhart; Jonathan W Engle Journal: Nucl Med Biol Date: 2021-03-03 Impact factor: 2.408